SCHEMBL19730583

SCHEMBL19730583

CCOC(=O)c1cc(Br)c2c(c1Cl)OCC2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.43
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAOB P27338 1/20 0.42
PREP P48147 2/20 0.41
CYP4F2 P78329 1/20 0.39
CYP4A11 Q02928 1/20 0.39
KDM4E B2RXH2 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ACHE P22303 4/20 0.37
BAZ2B Q9UIF8 1/20 0.36
BAZ2A Q9UIF9 1/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TSHR P16473 1/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14126349 0.85 ALDH1A1 (0.38) NPSR1HPGDMEN1KMT2AKDM4E
SCHEMBL25892904 0.81 KDM4E (0.35) NPSR1HPGDMEN1KMT2AMAOB
SCHEMBL25315647 0.81 PARP1 (0.33)
SCHEMBL21729876 0.79 SMN1; SMN2 (0.41) KDM4EHSD17B10TSHR
SCHEMBL30863908 0.79 SMN1; SMN2 (0.41) KDM4EHSD17B10TSHR
SCHEMBL25891631 0.75 SLC5A2 (0.38)
SCHEMBL21729864 0.74
SCHEMBL20558746 0.73 KDM4E (0.39) HPGDKDM4EACHEALDH1A1HSD17B10
SCHEMBL25892869 0.73 ALDH1A1 (0.39) HPGDPREPKDM4EACHEALDH1A1
SCHEMBL20643215 0.73 HTR2A (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10889574-B2 Method for producing diphenylmethane derivative DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2021-01-12 US disclosed
US-10640496-B2 Method for producing diphenylmethane derivative DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2020-05-05 US disclosed
US-20190169174-A1 METHOD FOR PRODUCING DIPHENYLMETHANE DERIVATIVE DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2019-06-06 US disclosed
WO-2017217792-A1 METHOD FOR PRODUCING DIPHENYLMETHANE DERIVATIVE 주식회사 대웅제약 2017-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169174-A1 METHOD FOR PRODUCING DIPHENYLMETHANE DERIVATIVE SLC5A2, SLC5A1, SLC2A1 NPSR1 4331/4885HPGD 2644/4885MEN1 3985/4885
US-10640496-B2 Method for producing diphenylmethane derivative SLC5A2, SLC5A1, SLC2A1 NPSR1 4331/4885HPGD 2644/4885MEN1 3985/4885
US-10889574-B2 Method for producing diphenylmethane derivative SLC5A2, SLC5A1, SLC2A1 NPSR1 4331/4885HPGD 2644/4885MEN1 3985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.